SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
CLARK PAUL N

(Last) (First) (Middle)
4101 RESEARCH COMMONS
79 T.W. ALEXANDER DRIVE

(Street)
RESEARCH TRIANGLE PARK NC 27709

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
09/30/2009
3. Issuer Name and Ticker or Trading Symbol
Talecris Biotherapeutics Holdings Corp. [ TLCR ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
04/06/2010
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 9,696(1) I By the Paul and Carolyn Clark Revocable Trust of 2009
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Options (right to buy) 04/01/2010 03/27/2019 Common Stock 7,848(2) $16.63 I By the Paul and Carolyn Clark Revocable Trust of 2009
Explanation of Responses:
1. As of September 30, 2009, the filing date of the Reporting Person's Form 3, the number of shares reported in this row included 3,616 unvested shares of the Issuer's common stock that were granted to the Reporting Person on March 27, 2009. Such non-vested shares subsequently vested on April 1, 2010.
2. As of September 30, 2009, the filing date of the Reporting Person's form 3, the securities reported in this row consisted of unvested options to purchase the Issuer's common stock that were granted by the Issuer to the Reporting Person on March 27, 2009. These options subsequently vested and became exercisable on April 1, 2010.
Remarks:
The date of the original filing was September 30, 2009. This Amendment is being filed to correctly provide that certain of the reported securities were indirectly beneficially owned, as of September 30, 2009, by the Reporting Person.
/s/ John F. Gaither Jr., attorney in fact 04/09/2010
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.